Central nervous system demyelinating diseases: glial cells at the hub of pathology

VG Coutinho Costa, SES Araújo… - Frontiers in …, 2023 - frontiersin.org
Inflammatory demyelinating diseases (IDDs) are among the main causes of inflammatory
and neurodegenerative injury of the central nervous system (CNS) in young adult patients …

Autoreactive lymphocytes in multiple sclerosis: Pathogenesis and treatment target

R Liu, S Du, L Zhao, S Jain, K Sahay… - Frontiers in …, 2022 - frontiersin.org
Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system
(CNS) characterized by destruction of the myelin sheath structure. The loss of myelin leads …

LPA2 Contributes to Vascular Endothelium Homeostasis and Cardiac Remodeling After Myocardial Infarction

J Pei, L Cai, F Wang, C Xu, S Pei, H Guo… - Circulation …, 2022 - Am Heart Assoc
Rationale: Myocardial infarction (MI) is one of the most dangerous adverse cardiovascular
events. Our previous study found that lysophosphatidic acid (LPA) is increased in human …

Anti-inflammatory effects of siponimod in a mouse model of excitotoxicity-induced retinal injury

D Basavarajappa, V Gupta, N Chitranshi… - Molecular …, 2023 - Springer
Glaucoma is a leading cause of permanent blindness worldwide and is characterized by
neurodegeneration linked to progressive retinal ganglion cell (RGC) death, axonal damage …

Disease-modifying therapies for relapsing/active secondary progressive multiple sclerosis–a review of population-specific evidence from randomized clinical trials

A Bayas, M Christ, S Faissner… - Therapeutic …, 2023 - journals.sagepub.com
Although the understanding of secondary progressive multiple sclerosis (SPMS) is evolving,
early detection of relapse-independent progression remains difficult. This is further …

Innovative drug delivery strategies to the CNS for the treatment of multiple sclerosis

A Mwema, GG Muccioli, A Des Rieux - Journal of Controlled Release, 2023 - Elsevier
Disorders of the central nervous system (CNS), such as multiple sclerosis (MS) represent a
great emotional, financial and social burden. Despite intense efforts, great unmet medical …

S1PR1 signaling attenuates apoptosis of retinal ganglion cells via modulation of cJun/Bim cascade and Bad phosphorylation in a mouse model of glaucoma

D Basavarajappa, V Gupta, R Vander Wall… - FASEB …, 2023 - researchers.mq.edu.au
Glaucoma is a complex neurodegenerative disease characterized by optic nerve damage
and apoptotic retinal ganglion cell (RGC) death, and is the leading cause of irreversible …

[HTML][HTML] First in vivo fluorine-19 magnetic resonance imaging of the multiple sclerosis drug siponimod

L Starke, JM Millward, C Prinz, F Sherazi… - Theranostics, 2023 - ncbi.nlm.nih.gov
Theranostic imaging methods could greatly enhance our understanding of the distribution of
CNS-acting drugs in individual patients. Fluorine-19 magnetic resonance imaging (19 F …

Immune System and Brain/Intestinal Barrier Functions in Psychiatric Diseases: Is Sphingosine-1-Phosphate at the Helm?

D Martín-Hernández, M Muñoz-López… - International Journal of …, 2023 - mdpi.com
Over the past few decades, extensive research has shed light on immune alterations and the
significance of dysfunctional biological barriers in psychiatric disorders. The leaky gut …

Causal relationship between multiple sclerosis and cortical structure: a Mendelian randomization study

D Sun, R Wang, Q Du, Y Zhang, H Chen, Z Shi… - Journal of Translational …, 2024 - Springer
Background Observational studies have suggested an association between multiple
sclerosis (MS) and cortical structure, but the results have been inconsistent. Objective We …